Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/92665
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaliba, Andrea-
dc.contributor.authorAgius, Donatella-
dc.contributor.authorSciberras, Edith-
dc.contributor.authorCamilleri, Nigel-
dc.date.accessioned2022-03-30T14:58:54Z-
dc.date.available2022-03-30T14:58:54Z-
dc.date.issued2018-
dc.identifier.citationSaliba, A. (2018). A population service evaluation of the attention deficit hyperactivity disorder pathway of children and young people’s services, Malta. Chronicles of Pharmaceutical Science, 2, 453-461.en_GB
dc.identifier.issn25727761-
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/92665-
dc.description.abstractBackground: Attention Deficit Hyperactivity Disorder (ADHD) is the commonest neurodevelopmental disorder in young people (YP) aged 5-18 years. YP with untreated ADHD are five times more likely to develop co-morbid psychiatric disorders. The aims were to carry out a population service evaluation of the assessment process and management of YP with ADHD at the Children and Young People’s Service (CYPS), Malta ages 0-16 years for 2014. Also to describe the service input, assessment and treatment of YP attending CYPS and compare to ADHD NICE guidelines 2008.en_GB
dc.description.abstractMethods: All YP diagnosed with ADHD at CYPS throughout 2014 were included. The incidence of YP with ADHD on treatment age 3-16 years in Malta was calculated. Information was collected from; i. Retrospective case file review and ii. Methylphenidate and Atomoxetine registry and compared with NICE guidelines.en_GB
dc.description.abstractResults: 136 YP were diagnosed with ADHD. The minimum 12-month incidence of ADHD on treatment (3-16 years) in Malta was 553 per 100,000. Pre-diagnosis assessments were more frequently performed by other YP services (n = 97, 71.3%, p = < 0.01). A psychiatrist or paediatrician confirmed the diagnosis in 113 (83.1%) YP. 62 (45.3%) YP were prescribed medication, 50 (36.8%) were referred for parental skills course and 55 (40.4%) for psychotherapy. The mean waiting time for the first appointment was 187.6 days (CI ± 26.9, 0-720), and 301.0 days (CI ± 34.4, 0-800) for the first specialist review.en_GB
dc.description.abstractConclusions: The incidence for YP (3-16 years) with ADHD on treatment was lower than the US. Since most pre-diagnostic assessments were carried out by other services, this raised the question about the reliability and validity. We recommend a diagnostic multidisciplinary team meeting following the multimodal assessment to diagnose ADHD. Medication prescribing followed NICE overall however standardising non-pharmacological management is required.en_GB
dc.language.isoenen_GB
dc.publisherScientia Ricercaen_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectAttention-deficit hyperactivity disorderen_GB
dc.subjectPsychiatric referralen_GB
dc.subjectAttention-deficit hyperactivity disorder -- Childrenen_GB
dc.subjectAttention-deficit hyperactivity disorder -- Middle-aged personsen_GB
dc.subjectPsychopharmacologyen_GB
dc.titleA population service evaluation of the attention deficit hyperactivity disorder pathway of children and young people’s services, Maltaen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.publication.titleChronicles of Pharmaceutical Scienceen_GB
Appears in Collections:Scholarly Works - FacM&SPsy



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.